Ramipril in High-Risk Patients With COVID-19

BACKGROUND: Coronavirus disease-2019 (COVID-19) is caused by severe acute respiratory-syndrome coronavirus-2 that interfaces with the renin-angiotensin-aldosterone system (RAAS) through angiotensin-converting enzyme 2. This interaction has been proposed as a potential risk factor in patients treated...

Descripción completa

Detalles Bibliográficos
Autores principales: Amat-Santos, Ignacio J., Santos-Martinez, Sandra, López-Otero, Diego, Nombela-Franco, Luis, Gutiérrez-Ibanes, Enrique, Del Valle, Raquel, Muñoz-García, Erika, Jiménez-Diaz, Víctor A., Regueiro, Ander, González-Ferreiro, Rocío, Benito, Tomás, Sanmartin-Pena, Xoan Carlos, Catalá, Pablo, Rodríguez-Gabella, Tania, Delgado-Arana, Jose Raúl, Carrasco-Moraleja, Manuel, Ibañez, Borja, San Román, J. Alberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: by the American College of Cardiology Foundation. Published by Elsevier. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7250557/
https://www.ncbi.nlm.nih.gov/pubmed/32470515
http://dx.doi.org/10.1016/j.jacc.2020.05.040

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7250557/
https://www.ncbi.nlm.nih.gov/pubmed/32470515
http://dx.doi.org/10.1016/j.jacc.2020.05.040

Ejemplares similares